Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: AR101

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Aimmune to Submit FDA Application for Peanut OIT Candidate by End...

Results of Phase III Trial of Aimmune's Peanut OIT Therapy

Aimmune Issues Update on AR101 Peanut Oral Immunotherapy Candidate

Aimmune, Regeneron and Sanofi Collaborate on Combination Peanut Therapy

Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut...

Breakthrough Food Allergy Therapies and the Big Business Behind Them

Follow Us

Your School On Our Map

Put Your School on the Map